Kalbe Farma (Indonesia) Buy Hold or Sell Recommendation
| KLBF Stock | IDR 1,485 20.00 1.37% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Kalbe Farma Tbk is 'Strong Sell'. The recommendation algorithm takes into account all of Kalbe Farma's available fundamental, technical, and predictive indicators you will find on this site.
Check out Kalbe Farma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Kalbe and provide practical buy, sell, or hold advice based on investors' constraints. Kalbe Farma Tbk. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Kalbe |
Execute Kalbe Farma Buy or Sell Advice
The Kalbe recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Kalbe Farma Tbk. Macroaxis does not own or have any residual interests in Kalbe Farma Tbk or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Kalbe Farma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Kalbe Farma Trading Alerts and Improvement Suggestions
| Kalbe Farma Tbk generated a negative expected return over the last 90 days | |
| About 58.0% of the company outstanding shares are owned by corporate insiders |
Kalbe Farma Returns Distribution Density
The distribution of Kalbe Farma's historical returns is an attempt to chart the uncertainty of Kalbe Farma's future price movements. The chart of the probability distribution of Kalbe Farma daily returns describes the distribution of returns around its average expected value. We use Kalbe Farma Tbk price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Kalbe Farma returns is essential to provide solid investment advice for Kalbe Farma.
| Mean Return | -0.26 | Value At Risk | -2.79 | Potential Upside | 2.64 | Standard Deviation | 1.53 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Kalbe Farma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Kalbe Farma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Kalbe Farma or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Kalbe Farma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Kalbe stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.25 | |
β | Beta against Dow Jones | -0.12 | |
σ | Overall volatility | 1.57 | |
Ir | Information ratio | -0.24 |
Kalbe Farma Volatility Alert
Kalbe Farma Tbk exhibits very low volatility with skewness of 0.38 and kurtosis of 0.3. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Kalbe Farma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Kalbe Farma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Kalbe Farma Fundamentals Vs Peers
Comparing Kalbe Farma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Kalbe Farma's direct or indirect competition across all of the common fundamentals between Kalbe Farma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Kalbe Farma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Kalbe Farma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Kalbe Farma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Kalbe Farma to competition |
| Fundamentals | Kalbe Farma | Peer Average |
| Return On Equity | 0.17 | -0.31 |
| Return On Asset | 0.11 | -0.14 |
| Profit Margin | 0.12 % | (1.27) % |
| Operating Margin | 0.15 % | (5.51) % |
| Current Valuation | 95.3 T | 16.62 B |
| Shares Outstanding | 46.26 B | 571.82 M |
| Shares Owned By Insiders | 58.08 % | 10.09 % |
| Shares Owned By Institutions | 15.23 % | 39.21 % |
| Price To Book | 5.06 X | 9.51 X |
| Price To Sales | 3.36 X | 11.42 X |
| Revenue | 26.26 T | 9.43 B |
| Gross Profit | 11.11 T | 27.38 B |
| EBITDA | 4.54 T | 3.9 B |
| Net Income | 3.18 T | 570.98 M |
| Cash And Equivalents | 3.32 T | 2.7 B |
| Total Debt | 532.51 B | 5.32 B |
| Book Value Per Share | 420.94 X | 1.93 K |
| Cash Flow From Operations | 2.83 T | 971.22 M |
| Earnings Per Share | 72.54 X | 3.12 X |
| Price To Earnings To Growth | 3.54 X | 4.89 X |
| Target Price | 2345.0 | |
| Number Of Employees | 12.64 K | 18.84 K |
| Beta | 0.32 | -0.15 |
| Market Capitalization | 104.08 T | 19.03 B |
| Total Asset | 25.67 T | 29.47 B |
| Annual Yield | 0.01 % | |
| Net Asset | 25.67 T | |
| Last Dividend Paid | 35.0 |
Kalbe Farma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Kalbe . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 467401.0 | |||
| Daily Balance Of Power | 0.5 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 1470.0 | |||
| Day Typical Price | 1475.0 | |||
| Price Action Indicator | 25.0 | |||
| Period Momentum Indicator | 20.0 |
About Kalbe Farma Buy or Sell Advice
When is the right time to buy or sell Kalbe Farma Tbk? Buying financial instruments such as Kalbe Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Kalbe Farma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Compulsion Thematic Idea Now
Compulsion
Companies involved in research, development, and manufacturing of products with compulsion characteristics such as cigarettes, addictive drugs and alcohol. The Compulsion theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Compulsion Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Kalbe Stock
Kalbe Farma financial ratios help investors to determine whether Kalbe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kalbe with respect to the benefits of owning Kalbe Farma security.